Ulcerative Colitis Segmental Resection Subtotal Colectomy Restorative Proctocolectomy Toxic Megacolon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Guindi M, Riddell RH (2004) Indeterminate colitis. J Clin Pathol 57(12):1233–1244PubMedCrossRefGoogle Scholar
  2. 2.
    Leichtner AM, Jackson WD, Grand RJ (1996) Crohn’s disease. In: Walker WA, Durie PR, Hamilton JR et al (eds) Pediatric Gastroentestinal Disease. St. Louis, Mosby, pp 692–711Google Scholar
  3. 3.
    Hanauer SB, Sandborn W (2001) Management of Crohn’s disease in adults. Am J Gastroenterol 96:635–643PubMedCrossRefGoogle Scholar
  4. 4.
    Glickman RM (1998) Inflammatory bowel disease: ulcerative colitis and Crohn’s disease. In: Fauci AS et al (eds) Harrison’s textbook of internal medicine, 14th edn. McGraw-Hill, New York, pp 1633–1645Google Scholar
  5. 5.
    Hyams JS (1996) Crohn’s disease in children. Pediat Clin N Am 100:235–254Google Scholar
  6. 6.
    Summers RW, Switz DM, Sessions JT Jr, and National Cooperative Crohn’s Disease Study (1979) Results of drug treatment. Gastroenterology 77:847–869PubMedGoogle Scholar
  7. 7.
    Hanauer SB, Krawitt EL, Robinson M, Pentasa Crohn’s Disease Compassionate Use Study Group (1993) Longterm management of Crohn’s disease with mesalamine capsules (Pentasa). Am J Gastroenterol 88:1343–1451PubMedGoogle Scholar
  8. 8.
    Wojciechowski K, Jarosz M (2001) Conservative treatment of Crohn’s disease: possibilities and limitations. Proktologia 3(2):226–239Google Scholar
  9. 9.
    Malchov H, Ewe K, Brandes JW (1984) European Cooperative Crohn’s Disease Study: results of drug treatment. Gastroenerology 86:249–266Google Scholar
  10. 10.
    Stange EF (1996) Steroid dependent and steroid refractory Crohn’s disease: definition by indices. Abstract of invited lectures. Falk Symposium No. 96, Oct. 1996, FreiburgGoogle Scholar
  11. 11.
    Thomsen OO (2002) Budesonide and masalazine in active Crohn’s disease: a comparison of the effects on quality of life. Am J Gastroenterol 97:649–653PubMedCrossRefGoogle Scholar
  12. 12.
    Salemans J, Hoitsma AJ, De Abreu RA (1987) Pharmacokinetics of azathioprine and 6-mercaptopurine after oral administration of azathioprine. Clin Transplant 1:217–221Google Scholar
  13. 13.
    Brynskov J, Freund L, Rasmunssen SN (1991) A final report on placebo-controlled double blind, randomized trial of cyclosporine treatment in active Crohn’s Disease. Scan J Gastroenterol 26:689–695Google Scholar
  14. 14.
    Sandborn WJ (1995) A critical review of cyclosporine therapy in inflammatory bowel disease. Inflam Bowel Dis (CCFA) 1:48–95CrossRefGoogle Scholar
  15. 15.
    Rutgeerts P, van Assche G, Vermeire S (2004) Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology 126:1593–1610PubMedCrossRefGoogle Scholar
  16. 16.
    Hanauer SB (2002) Maintenance infliximab for Crohn’s disease: the ACCENT I randomized trial. Lancet 359:1541–1549PubMedCrossRefGoogle Scholar
  17. 17.
    Hanauer SB (2002) Maintenance infliximab for Crohn’s disease: the ACCENT II in patients with fistulizing Crohn’s disease. Lancet 359:1541–1549PubMedCrossRefGoogle Scholar
  18. 18.
    Szczygieł B (2001) Nutritional treatment in Crohn’s disease. Proctology 2(3):240–246Google Scholar
  19. 19.
    Greenberg GR, Fleming CR, Jeejeebhoy JW (1988) Controlled trial on bowel rest and nutritional support in the management of Crohn’s disease. Gut 29:1309PubMedGoogle Scholar
  20. 20.
    Borley NR, Mortensen NJ, Jewell DP (1997) Preventing postoperative recurrence of Crohn’s disease. Br J Surg 84:1493–1502PubMedCrossRefGoogle Scholar
  21. 21.
    Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and recurrence in 907 patients with primary ileocecal Crohn’s disease. Br J Surg 87:1697–1701PubMedCrossRefGoogle Scholar
  22. 22.
    Fichera A, McCormack R, Rubin MA et al (2005) Longterm outcome of surgically treated Crohn’s colitis: a prospective study. Dis Colon Rectum 48(5):963–969PubMedCrossRefGoogle Scholar
  23. 23.
    Andrews HA, Lewis P, Allan RN (1989) Prognosis after surgery for colonic Crohn’s disease. Br J Surg 76:1184–1190PubMedGoogle Scholar
  24. 24.
    Andrews HA, Keighley MR, Alexander-Williams J, Allan RN (1991) Strategy for management of distal ileal Crohn’s disease. Br J Surg 78:79–82Google Scholar
  25. 25.
    Venkatesh KS, Ramanujan PS, McGee S (1992) Hydrostatic balloon dilatation of benign colonic anastomotic strictures. Dis Colon Rectum 35:789–791PubMedCrossRefGoogle Scholar
  26. 26.
    Kennedy HK (2004) Quality of life in patients with an ileostomy. Int Disibil Stud 59(1):23–29Google Scholar
  27. 27.
    Dziki A, Galbfach P (2004) Crohn’s disease: when to operate? Acta Chir Iugosl 51(2):61–68PubMedGoogle Scholar
  28. 28.
    Hyman NH, Cataldo P, Osler T (2005) Urgent subtotal colectomy for severe inflammatory bowel disease. Dis Colon Rectum 48(1):70–73PubMedCrossRefGoogle Scholar
  29. 29.
    Mylonakis E, Allan RN, Keighley MR (2001) How does pouch construction for a final diagnosis of Crohn’s disease compare with ileoproctostomy for established Crohn’s proctocolitis? Dis Colon Rectum 44(8):1137–1142PubMedCrossRefGoogle Scholar
  30. 30.
    Panis Y, Poupard B, Nementh J (1996) Ileal pouch/anal anastomosis for Crohn’s disease. Lancet 347:854–857PubMedCrossRefGoogle Scholar
  31. 31.
    Cattan P, Bonhomme N, Panis Y (2002) Fate of rectum in patients undergoing total colectomy for Crohn’s disease. Br J Surg 89:454–459PubMedCrossRefGoogle Scholar
  32. 32.
    Anderson P, Olaison G, Hallbook O, Sjodahl R (2002) Segmental resection or subtotal colectomy in Crohn’s colitis? Dis Colon Rectum 45:47–53CrossRefGoogle Scholar
  33. 33.
    Longo WE, Ballantyne GH, Cahow CE (1988) Treatment of Crohn’s colitis: segmental or total colectomy? Arch Surg 123(5):588–590PubMedGoogle Scholar
  34. 34.
    Roy P, Kumar D (2005) Strictureplasty for active Crohn’s disease. Int J Colorectal Dis 30:1–6Google Scholar
  35. 35.
    Lange de EF, Shaffer HA Jr (1991) Rectal strictures: treatment with fluoroscopically guided balloon dilation. Radiology 178(2):475–479PubMedGoogle Scholar
  36. 36.
    Solt JU, Hertelendy A, Szilagyi K (2004) Long-term results of balloon catheter dilation of lower gastrointestinal tract stenoses. Dis Colon Rectum 47(9):1499–1505PubMedGoogle Scholar
  37. 37.
    Sabate JM, Villarejo J, Bouhnik Y et al (2003) Hydrostatic balloon dilatation of Crohn’s strictures. Alimet Pharmacol Ther 18(4):409–413CrossRefGoogle Scholar
  38. 38.
    Skreden K, Wiig JN, Myrvold HE (1987) Balloon dilation of rectal strictures. Acta Chir Scand 153(10):615–617PubMedGoogle Scholar
  39. 39.
    Legnani PE, Krnbluth A (2002) Therapeutic options in the management of strictures in Crohn’s disease. Gastrointest Endosc Clin N Am 12(3):589–603PubMedCrossRefGoogle Scholar
  40. 40.
    Couckuyt H, Geveres AM, Corenmans G et al (1995) Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective long-term analysis. Gut 36(4):577–580PubMedGoogle Scholar
  41. 41.
    Virgilio C, Cosentino S, Favara C at al (1995) Endoscopic treatment of postoperative colonic strictures using an achalasia dilator: short-term and long-term results. Endoscopy 27(3):219–222PubMedGoogle Scholar
  42. 42.
    Schwartz DA, Loftus EV Jr, Tremaine WJ et al (2002) The natural history of fistulizing Crohn’s disease in Olmstead County, Minnesota. Gastroenterology 122:875–880PubMedCrossRefGoogle Scholar
  43. 43.
    Levy C, Tremaine WJ (2002) Management of internal fistulas in Crohn’s disease. Inflamm Bowel Dis 8:106–111PubMedCrossRefGoogle Scholar
  44. 44.
    Present DH (2003) Crohn’s fistula: current concepts in Management. Gastroenterology 124:1629–1635PubMedCrossRefGoogle Scholar
  45. 45.
    Present DH, Korelitz BI, Wisch N et al (1980) Treatment of Crohn’s disease with 6 Mercaptopurine: a long term randomized double blind study. N Engl J Med 302:981–987PubMedCrossRefGoogle Scholar
  46. 46.
    Korelitz BI, Present DH (1985) The favorable effects of 6 mercaptopurine in the fistulous Crohn’s disease. Dig Dis Sci 30:58–64PubMedCrossRefGoogle Scholar
  47. 47.
    Pearson DC, May GR, Fick GH, Sutherland LR (1995) Azathioprine and 6 mercaptopurine in Crohn’s disease: a meta-analysis. Ann Intern Med 123:132–142PubMedGoogle Scholar
  48. 48.
    Sample C, Bailey RJ, Todoruk D et al (2002) Clinical experience with infliximab for Crohn’s disease: the first 100 patients in Edmonton, Alberta. Can J Gastroenterol 16:165–170PubMedGoogle Scholar
  49. 49.
    Arnott ID, McDonald D, Wiliams A, Ghosh S (2001) Clinical use of Infliximab in Crohn’s disease: the Edinburgh experience. Aliment Pharmacol Ther 15:1639–1646PubMedCrossRefGoogle Scholar
  50. 50.
    Ricart E, Panaccione R, Loftus EV et al (2001) Infliximab for Crohn’s disease in clinical practice at the Mayo Clinic: the first 100 patients. Am J Gastroenterol 96:722–729PubMedCrossRefGoogle Scholar
  51. 51.
    Goligher JC (1985) The long-term results of excisional surgery for primary and recurrent Crohn’s disease of the large intestine. Dis Colon Rectum 28:51–55PubMedCrossRefGoogle Scholar
  52. 52.
    Longo WE, Ballantyne GH, Cahow CE (1988) Treatment of Crohn’s colitis: segmental or total colectomy? Arch Surg 123:588–590PubMedGoogle Scholar
  53. 53.
    Parsi MA, Lashner BA, Achkar JP et al (2004) Type of fistula determines response to infliximab in patients with fistulous Crohn’s disease. Am J Gastroenterol 99:445–449PubMedCrossRefGoogle Scholar
  54. 54.
    Colombel J-F, Loftus EV Jr, Tremaine WJ et al (2004) The safety profile of infliximab in patients with Crohn’s disease: the Mayo Clinic experience in 500 patients. Gastroenterology 126:19–31PubMedCrossRefGoogle Scholar
  55. 55.
    Whelan G, Farmer RG, Fazio VW, Goormastic M (1985) Recurrence after surgery in Crohn’s disease. Gastroenterology 88:1826–1833PubMedGoogle Scholar
  56. 56.
    Basilisco G, Campanini M, Cesana B et al (1989) Risk factors for first operation in Crohn’s disease. Am J Gastroenterol 84:749–752PubMedGoogle Scholar
  57. 57.
    Andersson P, Olaison G, Hallbook O, Sjodahl R (2002) Segmental resection or subtotal colectomy in Crohn’s colitis? Dis Colon Rectum 45:47–53PubMedCrossRefGoogle Scholar
  58. 58.
    Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg 231:38–45PubMedCrossRefGoogle Scholar
  59. 59.
    Allan A, Andrews H, Hilton CJ et al (1989) Segmental colonic resection is an appropriate operation for short skip lesions due to Crohn’s disease in the colon. Word J Surg 13:611–616CrossRefGoogle Scholar
  60. 60.
    Goligher JC (1988) Surgical treatment of inflammatory bowel disease-introduction. World J Surg 12:139–141PubMedCrossRefGoogle Scholar
  61. 61.
    Polle SW, Slors JFM, Weverling GJ et al (2005) Recurrence after segmental resection for colonic Crohn’s disease. Br J Surg 92:1143–1149PubMedCrossRefGoogle Scholar
  62. 62.
    Prabhakar LP, Laramee C, Nelson H, Dozois RR (1997) Avoiding a stoma: role for segmental or abdominal colectomy in Crohn’s colitis. Dis Colon Rectum 40:71–78PubMedCrossRefGoogle Scholar
  63. 63.
    Stern HS, Goldberg SM, Rothenberger DA (1984) Segmental versus total colectomy for large bowel Crohn’s disease. World J Surg 8:118–122PubMedCrossRefGoogle Scholar
  64. 64.
    Bernell O, Lapidus A, Hellers G (2001) Recurrence after colectomy in Crohn’s colitis. Dis Colon Rectum 44: 647–654PubMedCrossRefGoogle Scholar
  65. 65.
    Ambrose NS, Keighley MR (1984) Clinical impact of colectomy and ileorectal anastomosis in the management of Crohn’s disease. Gut 25:223–227PubMedGoogle Scholar
  66. 66.
    Flint G, Strauss R (1977) Ileorectal anastomosis in patients with Crohn’s disease of the colon. Gut 18:236–239PubMedGoogle Scholar
  67. 67.
    Lock MR, Fazio VW, Farmer RG (1981) Proximal recurrence and the fate of the rectum following excisional surgery for Crohn’s disease of the large bowel. Ann Surg 194:754–760PubMedCrossRefGoogle Scholar
  68. 68.
    Yamamoto T, Bain IM, Mylonakis E et al (1993) Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn’s disease. Scand J Gastroenterol 34:708–713CrossRefGoogle Scholar
  69. 69.
    Hashemi M, Novell JR, Lewis AAM (1988) Side-to-side stapled anastomosis may delay recurrence in Crohn’s disease. Dis Colon Rectum 41:1293–1296CrossRefGoogle Scholar
  70. 70.
    Yamamoto T (2005) Factors affecting recurrence after surgery for Crohn’s disease. World J Gastroenterol 11:3971–3979PubMedGoogle Scholar
  71. 71.
    Cosnes J, Beaugerie L, Carbonnel F, Gendre JP (2001) Smoking cessation and the course of Crohn’s disease: an intervention study. Gastroenterology 120:1093–1099PubMedCrossRefGoogle Scholar
  72. 72.
    Ryan WR, Allan RN, Yamamoto T, Keighley MR (2004) Crohn’s disease patients who quit smoking have a reduced risk of reoperation for recurrence. Am J Surg 187: 219–225PubMedCrossRefGoogle Scholar
  73. 73.
    Lautenbach E, Berlin JA, Lichtenstein GR (1998) Risk factors for early postoperative recurrence of Crohn’s disease. Gastroenterology 115:256–267CrossRefGoogle Scholar
  74. 74.
    Cottone M, Orlando A, Viscido A (2003) Review article: prevention of postsurgical relapse and recurrence in Crohn’s disease. Aliment Pharmacol Ther 17:(Suppl 2):38–42PubMedCrossRefGoogle Scholar
  75. 75.
    Bernstein CN, Blanchard JF, Kliewer E, Wajda A (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 15:854–862CrossRefGoogle Scholar
  76. 76.
    Mpofu C, Watson AJ, Rhodes JM (2004) Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2:CD000279PubMedGoogle Scholar
  77. 77.
    Shanahan F (2003) Colitis-associated cancer: time for new strategies. Aliment Pharmacol Ther 18(Suppl 2):6–9PubMedCrossRefGoogle Scholar
  78. 78.
    Gillen CD, Andrews HA, Prior P, Allan RN (1994) Crohn’s disease and colorectal cancer. Gut 35:651–656PubMedGoogle Scholar
  79. 79.
    Greenstein AJ (2000) Cancer in inflammatory bowel disease. Mt Sinai J Med 67:227–240PubMedGoogle Scholar
  80. 80.
    Greenstein AJ, Sachar DB, Smith H et al (1981) A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 48:2742–2745PubMedCrossRefGoogle Scholar
  81. 81.
    Clemmens T, Johansen A (1972) A case of Crohn’s disease of the colon associated with adenocarcinoma extending from cardia to the anus. Acta Pathol Microbiol Scand 80:5–8Google Scholar
  82. 82.
    Keighley MRB, Thompson H, Alexander-Williams J (1975) Multifocal colonic carcinoma and Crohn’s disease. Surgery 78:534–537PubMedGoogle Scholar
  83. 83.
    Gillen CD, Andrews HA, Prior P, Allan RN (1994) Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35:1590–1592PubMedGoogle Scholar
  84. 84.
    Eckbom A, Helmick C, Zack M, Adami HO (1990) Increased risk of large bowel cancer in Crohn’s disease with colonic involvement. Lancet 336:357–359CrossRefGoogle Scholar
  85. 85.
    Sachar DB (1994) Cancer in Crohn’s disease: dispelling the myths. Gut 35:1507–1508PubMedGoogle Scholar
  86. 86.
    Greenstein AJ, Slater G, Heimann TM et al (1986) A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg 203:123–128PubMedCrossRefGoogle Scholar
  87. 87.
    Yamazuki Y, Ribeiro MB, Sachar DB et al (1991) Malignant colorectal strictures in Crohn’s disease. Am J Gastroenterol 86:882–885Google Scholar
  88. 88.
    Greenstein AJ, Sachar D, Pucillo A et al (1978) Cancer in Crohn’s disease after diversionary surgery: a report of seven carcinomas occurring in excluded bowel. Am J Surg 135:86–90PubMedCrossRefGoogle Scholar
  89. 89.
    Sher ME, Bauer JJ, Gelernt I (1991) Surgical repair of rectovaginal fistulas in patients with Crohn’s disease: transvaginal approach. Dis Colon Rectum 34:641–648PubMedCrossRefGoogle Scholar
  90. 90.
    Church JM, Weakley FI, Fazio VW et al (1985) The relationship between fistulas in Crohn’s disease and associated carcinoma: report of four cases and review of the literature. Dis Colon Rectum 28:361–366PubMedCrossRefGoogle Scholar
  91. 91.
    Berg DF, Bahadursingh AM, Kamiński DL, Longo WE (2002) Acute surgical emergencies in inflammatory bowel disease. Am J Surg 184:45–51PubMedCrossRefGoogle Scholar
  92. 92.
    Hyman NH, Cataldo P, Mosler T (2005) Urgent subtotal colectomy for severe inflammatory bowel disease. Dis Colon Rectum 48:70–73PubMedCrossRefGoogle Scholar
  93. 93.
    Katz JA (2000) Medical and surgical management of severe colitis. Semin Gastrointest Dis 11:18–32PubMedGoogle Scholar
  94. 94.
    Yamamoto T, Allan RN, Keighley RB (2000) Audit of single-stage proctocolectomy for Crohn’s disease: postoperative complications and recurrence. Dis Colon Rectum 43:249–256PubMedCrossRefGoogle Scholar
  95. 95.
    Parc YR, Radice E, Dozois RR (1999) Burgery for ulcerative colitis: historical perspective: a century of surgical innovations and refinements. Dis Colon Rectum 42:299–306PubMedCrossRefGoogle Scholar
  96. 96.
    Sirocco WC, Reilly JC, Rusin LC (1995) Life threatening hemorrhage and exsanguination from Crohn’s disease. Dis Colon Rectum 38:85–95CrossRefGoogle Scholar
  97. 97.
    Balaiche J, Louis E, D’Haens G et al (1999) Acute lower gastrointestinal bleeding in Crohn’s disease: characteristics of a unique series of 34 patients: Belgia IBD Research Group. Am J Gastroenterol 94:2177–2181CrossRefGoogle Scholar
  98. 98.
    Tsujikawa T, Nezu R, Andoh A et al (2004) Infliximab as a possible treatment for the hemorrhagic type of Crohn’s disease. J Gastroenterol 39:284–287PubMedCrossRefGoogle Scholar
  99. 99.
    Veroux M, Angriman I, Ruffolo C et al (2003) A rare surgical complication of Crohn’s disease: free peritoneal perforation. Minerva Chir 58:351–354PubMedGoogle Scholar
  100. 100.
    Greenstein AJ, Aufses AH Jr (1985) Differences in pathogenesis, incidence and outcome of perforation in inflammatory bowel disease. Surg Gynecol Obstet 160:63–69PubMedGoogle Scholar
  101. 101.
    Bortnik M, Lukas M (2001) Toxic megacolon. Cas Lek Cesk 140:619–623Google Scholar
  102. 102.
    Levine CD (1999) Toxic megacolon: diagnosis and treatment challenges. AACN Clin Issues 10:492–499PubMedCrossRefGoogle Scholar
  103. 103.
    Gsell O, Loew E (1960) Toxic megacolon in ulcerative colitis. Gastroenterol 94:29–47CrossRefGoogle Scholar
  104. 104.
    Yamazaki Y, Ribeiro MB, Sachar DB et al (1991) Malignant strictures in Crohn’s disease. Am J Gastrenterol 86:882–885Google Scholar

Copyright information

© Springer-Verlag Italia 2006

Authors and Affiliations

  • Adam Dziki
    • 1
  1. 1.Department of General and Colorectal SurgeryMedical UniversityLodzPoland

Personalised recommendations